Pancreatic Cancer Research

ResearcherUniversity of Chemistry and Technology, PragueNo recent work listed

Tomáš Ruml

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5698-4366; OpenAlex author ID A5057667007. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 6

  1. Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins. Co-author DOI 10.3390/molecules26123528↗
  2. Variability in statin-induced changes in gene expression profiles of pancreatic cancer. Co-author DOI 10.1038/srep44219↗
  3. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells. Co-author DOI 10.1186/s12944-017-0641-0↗
  4. Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells. Co-author DOI 10.1186/s12885-016-2343-9↗
  5. Antiproliferative effects of carbon monoxide on pancreatic cancer. Last author DOI 10.1016/j.dld.2013.12.007↗
  6. The effect of simvastatin on lipid droplets accumulation in human embryonic kidney cells and pancreatic cancer cells. Last author DOI 10.1186/1476-511x-12-126↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Helena Gbelcová · 6 shared papers, 2013–2021 · strength 0.43
  2. Libor Vı́tek · 6 shared papers, 2013–2021 · strength 0.43
  3. Silvie Rimpelová · 3 shared papers, 2017–2021 · strength 0.29
  4. Katerina Hadrava Vanova · 2 shared papers, 2014–2016 · strength 0.10
  5. R Gürlich · 1 shared paper, 2016 · strength 0.06
  6. Jiřı́ Neužil · 1 shared paper, 2016 · strength 0.06
  7. Štěpána Boukalová · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.